ICYMI, this week we had stories about non-prescription acne treatments, clinical study results, pediatric atopic dermatitis, and the EADV 2022 Congress.
Click here to answer this week's poll.
Expert dermatologists discuss the impact of nonprescription acne treatment on quality of life and function.
Expert acne specialists discuss the types of cleansers available on the market.
This week's edition of the Mainstream Patient features stories about tattoo aftercare, expert-reviewed wrinkle creams, trending Latinx beauty brands, and more.
Timber Pharmaceuticals’ CONTROL study evaluated the safety and efficacy of the topical isotretinoin.
New research by the National Eczema Association has revealed the importance of patient input into treatment decisions.
Positioning your portfolio for price stability and growth.
Dr Joshua Zeichner reviews the case of a 2-year-old patient with atopic dermatitis.
Expert pediatric dermatologists Drs Elizabeth Swanson, Joshua Zeichner, and Raj Chovatiya share impressions from patient case No. 1.
Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, discuss treatments beyond topical agents and the use of dupilumab in pediatric patients with atopic dermatitis.
Dr Joshua Zeichner reviews the case of a 7-year-old female patient with atopic dermatitis.
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses how to treat tinea versicolor.
Abstracts will include updates on treatment for psoriatic arthritis, psoriasis, atopic dermatitis, and more.
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of August.
Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; and Vikash Oza, MD, address techniques for injectables when treating pediatric patients with atopic dermatitis.
Vikash Oza, MD, provides clinical insight for Case 2, a 7-year-old female patient with atopic dermatitis.
Brittany Craiglow, MD, and Joshua Zeichner, MD, discuss treatment adherence in pediatric patients with atopic dermatitis.
Expert pediatric dermatologists discuss the importance of combination therapy and shared decision-making when treating pediatric patients with atopic dermatitis.
Topline data expected in the first half of 2023.
AnaptysBio will refocus R&D efforts on its immune cell modulator pipeline.
Revelle Aesthetics’ cellulite reduction device helps address frustrating aesthetic concerns.
Boehringer Ingelheim’s first treatment option for adults will help manage burdensome flares.